Thoracic Surgery Market: Industry Analysis and Forecast (2021-2029)

Thoracic Surgery Market was valued at USD 3.1 Billion in 2021, and it is expected to reach USD 5.40 Billion by 2029, exhibiting a CAGR of 7.18 % during the forecast period (2022-2029).

Thoracic Surgery Market Overview:

Thoracic surgery refers to operations on organs in the chest, including the heart, lungs, and oesophagus. Examples of thoracic surgery include coronary artery bypass surgery, heart transplant, lung transplant, and removal of parts of the lung affected by cancer. The report explores the Thoracic Surgery Market’s segments (Connectivity and Content, and Distribution Channel). Data has been provided by market participants, and Distribution Channel (North America, Asia Pacific, Europe, Middle East & Africa, and South America). The MMR market report provides a thorough analysis of the rapid advances that are currently taking place across all Devices sectors. Facts and figures, illustrations, and presentations are used to provide key data analysis for the historical period from 2017 to 2022. The report investigates the Thoracic Surgery Market’s drivers, limitations, prospects, and barriers. This MMR report includes investor recommendations based on a thorough examination of the Thoracic Surgery Market’s contemporary competitive scenario. Thoracic Surgery Market To know about the Research Methodology :- Request Free Sample Report In the report, 2021 is considered as a base year to forecast the market from 2022 to 2029. 2021’s market size is estimated on real numbers and outputs of the key players and major players across the globe. Past five years' trends are considered while forecasting the market through 2029.

Thoracic Surgery Market Dynamics

Over the next seven years, the expanding geriatric population and rising cases of cardiac conditions respond in increased demand for cardiac surgeries, which propels the market growth. In addition, advantages of this surgery, such as reduced pain, low blood loss, low risk of infection, and rapidly healing with shorter hospitalization, supplement the growth. The global thoracic surgery market is witnessing several technological advancements in both minimally invasive(MI) surgeries and open procedures. Technological advancements in endoscopy have led to the development of ultra-MI thoracic procedures, which can be performed on patients with benign oesophageal condition and early- stage oesophageal cancer. However, a lack of skilled practitioners and stringent regulatory services may hinder the market growth. The report has profiled key players in the market from different regions. even so, report has considered all market leaders, followers and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, accessibility of advanced technology are analyzed and report has come up with recommendations for future hot spot in APAC region.

Thoracic Surgery Market Segment Analysis

MMR provides an analysis of the key trends in each sub-segment of the Blood Irradiator Device. Thoracic Surgery Market

Global Thoracic Surgery Market Segment Analysis

Based on Surgery Type, Lobectomy is the most frequently used procedure aimed to the treatment of lung cancer. The lobectomy segment is expected during forecasting period to dominate the global market remaining to its benefits such as shorter and median hospital length of stay, and improved two-year survival. Lobectomy eliminates the entire lobe of the lung that has cancer, including the lymph nodes. Lung Cancer accounts for more than 20% of the cancer deaths worldwide and is preventable due to the development of surgical procedures, which is estimated to increase the demand for the Minimally Invasive Surgery market. Based on Application, lung cancer is estimated to hold a prominent market share owed to the rising cases of lung cancer from the past decade. The surge in lung cancer cases, which is currently almost 85% of cancer patients globally, is due to the rise in long-lasting tobacco smoking in the world. The others segment includes surgical centers and other medical facilities that deliver limited access to advanced procedures due to their remote localities or because they challenge necessary infrastructure needed for advanced procedures suchlike as an operating room table with proper lighting equipment and surgical instruments storehouse space. These types of surgeries are performed by educated surgeons in lower than ideal conditions but still produce acceptable results due to their proficiency in handling tough situations where perfection isn't possible even though better outcomes can be expected compared with conventional techniques used for treatment purposes.

Thoracic Surgery Market Regional Insight

The North American End-User holds an XX% market share in global Human Growth Hormone. Aggregate demand for sophisticated and well-organized medical devices is driving the growth of the US market. Increasing medical costs, medical needs of the aging population, and the number of cases of Devices are also some of the drivers behind market growth. The pharmaceutical market is expected to grow rapidly, but political instability is now affecting the global economy as a whole. For example, Trump's trade war with China and the turmoil in the UK's Brevity process have created market uncertainty in the Thoracic Surgery Market. The pharmaceutical Devices tends to operate on a longer timescale throughout the political cycle, and business fundamentals are expected to be strong and very bullish during the forecast period. The objective of the report is to present a comprehensive analysis of the global Thoracic Surgery Market to the stakeholders in the Devices. The past and current status of the Devices with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the Devices with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the Devices to the decision-makers. The reports also help in understanding the Thoracic Surgery Market dynamic, structure by analysing the market segments and projecting the Thoracic Surgery Market size. Clear representation of competitive analysis of key players by Vehicle type, price, financial position, Devices portfolio, growth strategies, and End-Industrial presence in the Thoracic Surgery Market make the report investor’s guide.

Thoracic Surgery Market Scope: Inquire before buying

Global Thoracic Surgery Market
Report Coverage Details
Base Year: 2021 Forecast Period: 2022-2029
Historical Data: 2017 to 2021 Market Size in 2021: US$ 3.1 Bn.
Forecast Period 2022 to 2029 CAGR: 7.18 % Market Size in 2029: US$ 5.40  Bn
Segments Covered: by Surgery • Lobectomy • Wedge Resection • Pneumonectomy • Pleurectomy • Others
by Application • Lung Cancer • Esophageal Cancer • Gastroesophageal reflux • Others.
byEnd User • Hospital • Ambulatory Surgical Centers • Others.

Thoracic Surgery Market, by Region

• North America • Asia-Pacific • Europe • South America • Middle East and Africa

Thoracic Surgery Market Key Players

• Medtronic plc • Cardio medical GmbH • Intuitive Surgical • Richard Wolf GmbH • Grena Ltd. • Dextera Surgical Inc. • Teleflex Incorporated • Medela Healthcare • LivaNova plc • Sklar Surgical Instruments • Abbott Laboratories • Boston Scientific Corp. • Edwards Lifesciences Corp. • Biosensors International Group, Ltd. • BIOTRONIK SE & Co • BioVentrix, Inc. • C. R. Bard, Inc. • CardiacAssist, Inc. • Johnson & Johnson, Inc. Frequently Asked Questions: 1] What segments are covered in the Global Thoracic Surgery Market report? Ans. The segments covered in the Thoracic Surgery Market report are based on Surgery, Application and End-User. 2] Which End-User is expected to hold the highest share in the Global Thoracic Surgery Market? Ans. The Asia Pacific End-User is expected to hold the highest share in the Thoracic Surgery Market. 3] What is the market size of the Global Thoracic Surgery Market by 2029? Ans. The market size of the Thoracic Surgery Market by 2029 is expected to reach USD 5.40 Bn. 4] What is the forecast period for the Global Thoracic Surgery Market? Ans. The forecast period for the Thoracic Surgery Market is 2021-2029. 5] What was the market size of the Global Thoracic Surgery Market in 2021? Ans. The market size of the Thoracic Surgery Market in 2021 was valued at USD 3.1 Bn.
1. Global Thoracic Surgery Market: Research Methodology 2. Global Thoracic Surgery Market: Executive Summary 2.1. Market Overview and Definitions 2.1.1. Introduction to Global Thoracic Surgery Market 2.2. Summary 2.2.1. Key Findings 2.2.2. Recommendations for Investors 2.2.3. Recommendations for Market Leaders 2.2.4. Recommendations for New Market Entry 3. Global Thoracic Surgery Market: Competitive Analysis 3.1. MMR Competition Matrix 3.1.1. Market Structure by region 3.1.2. Competitive Benchmarking of Key Players 3.2. Consolidation in the Market 3.2.1 M&A by region 3.3. Key Developments by Companies 3.4. Market Drivers 3.5. Market Restraints 3.6. Market Opportunities 3.7. Market Challenges 3.8. Market Dynamics 3.9. PORTERS Five Forces Analysis 3.10. PESTLE 3.11. Regulatory Landscape by region ● North America ● Europe ● Asia Pacific ● The Middle East and Africa ● South America 3.12. COVID-19 Impact 4. Global Thoracic Surgery Market Segmentation 4.1. Global Thoracic Surgery Market, By Surgery (2021-2029) ● Lobectomy ● Wedge Resection ● Pneumonectomy ● Pleurectomy ● Others 4.2. Others Global Thoracic Surgery Market, By Application (2021-2029) ● Lung Cancer ● Esophageal Cancer ● Gastroesophageal reflux ● Others. 4.3. Global Thoracic Surgery Market, End User (2021-2029) ● Hospital ● Ambulatory Surgical Centers ● Others 5. North America Thoracic Surgery Market (2021-2029) 5.1. North America Thoracic Surgery Market, By Surgery (2021-2029) ● Lobectomy ● Wedge Resection ● Pneumonectomy ● Pleurectomy ● Others 5.2. North America Thoracic Surgery Market, By Application (2021-2029) ● Lung Cancer ● Esophageal Cancer ● Gastroesophageal reflux ● Others. 5.3. North America Thoracic Surgery Market, End User (2021-2029) ● Hospital ● Ambulatory Surgical Centers ● Others 5.4. North America Thoracic Surgery Market, by Country (2021-2029) ● United States ● Canada ● Mexico 6. European Thoracic Surgery Market (2021-2029) 6.1. European Thoracic Surgery Market, By Surgery (2021-2029) 6.2. European Thoracic Surgery Market, By Application (2021-2029) 6.3. European Thoracic Surgery Market, End User (2021-2029) 6.4. European Thoracic Surgery Market, by Country (2021-2029) ● UK ● France ● Germany ● Italy ● Spain ● Sweden ● Austria ● Rest of Europe 7. Asia Pacific Thoracic Surgery Market (2021-2029) 7.1. Asia Pacific Thoracic Surgery Market, By Surgery (2021-2029) 7.2. Asia Pacific Thoracic Surgery Market, By Application (2021-2029) 7.3. Asia Pacific Thoracic Surgery Market, End User (2021-2029) 7.4. Asia Pacific Thoracic Surgery Market, by Country (2021-2029) ● China ● India ● Japan ● South Korea ● Australia ● ASEAN ● Rest Of APAC 8. Middle East and Africa Thoracic Surgery Market (2021-2029) 8.1. Middle East and Africa Thoracic Surgery Market, By Surgery (2021-2029) 8.2. Middle East and Africa Thoracic Surgery Market, By Application (2021-2029) 8.3. Middle East and Africa Thoracic Surgery Market, End User (2021-2029) 8.4. Middle East and Africa Thoracic Surgery Market, by Country (2021-2029) ● South Africa ● GCC ● Egypt ● Nigeria ● Rest Of ME&A 9. South America Thoracic Surgery Market (2021-2029) 9.1. South America Thoracic Surgery Market, By Surgery (2021-2029) 9.2. South America Thoracic Surgery Market, By Application (2021-2029) 9.3. South America Thoracic Surgery Market, End User (2021-2029) 9.4. South America Thoracic Surgery Market, by Country (2021-2029) ● Brazil ● Argentina ● Rest of South America 10. Company Profile: Key players 10.1. Medtronic plc 10.1.1. Company Overview 10.1.2. Financial Overview 10.1.3. Global Presence 10.1.4. Capacity Portfolio 10.1.5. Business Strategy 10.1.6. Recent Developments 10.2. Medtronic plc 10.3. Cardio medical GmbH 10.4. Intuitive Surgical 10.5. Richard Wolf GmbH 10.6. Grena Ltd. 10.7. Dextera Surgical Inc. 10.8. Teleflex Incorporated 10.9. Medela Healthcare 10.10. LivaNova plc 10.11. Sklar Surgical Instruments 10.12. Abbott Laboratories 10.13. Boston Scientific Corp. 10.14. Edwards Lifesciences Corp. 10.15. Biosensors International Group, Ltd. 10.16. BIOTRONIK SE & Co 10.17. BioVentrix, Inc. 10.18. C. R. Bard, Inc. 10.19. CardiacAssist, Inc. 10.20. Johnson & Johnson, Inc.
  • INQUIRE BEFORE BUYING